查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1963826

心臟定位設備市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、適應症、最終用途、地區和競爭格局分類，2021-2031年

Cardiac Mapping Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Indication, By End-use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球心臟定位設備市場預計將從 2025 年的 29.9 億美元成長到 2031 年的 56.9 億美元，複合年成長率為 11.32%。

這些診斷設備在電生理手術中至關重要，它們利用導管感測器來收集並分析心臟的電訊號。透過建立精確的3D心腔模型，醫生可以準確地識別複雜心律不整（例如心房顫動）的解剖起源。這些設備提供的即時電訊號數據對於引導消融導管到達引起心律不整的特定組織至關重要，有助於改善心臟治療效果，從而提升患者的預後。

市場概覽
預測期 2027-2031
市場規模：2025年 29.9億美元
市場規模：2031年 56.9億美元
複合年成長率：2026-2031年 11.32%
成長最快的細分市場 關於心臟定位系統的諮詢
最大的市場 北美洲

市場成長的主要驅動力是全球心血管疾病的增加以及易患心律不整的老年人口不斷成長。此外，臨床上向依賴精準導航的微創消融技術的轉變也進一步推動了這項需求。歐洲心臟學會預測，到2025年，全球三分之一的人在其一生中的某個階段將面臨可能危及生命的心律不整。然而，儘管臨床需求迫切，但實施和維護這些系統的高昂成本對醫療基礎設施發展中資金有限的地區構成了重大障礙，阻礙了市場成長。

市場促進因素

心血管疾病和心律不整盛行率的不斷上升是市場成長的主要驅動力。隨著心房顫動等複雜心律不整發生率的增加，迫切需要能夠進行根治性消融手術的先進標測系統。這種流行病學負擔導致手術數量增加，並對精準診斷工具的需求日益成長。根據美國心臟協會 (AHA) 發布的《2024 年心血管疾病與中風統計》報告，心血管疾病仍是全球首要死因，每年約奪去 1,991 萬人的生命。此外，美國國家心肺血液研究所 (NHLBI) 估計，到 2024 年，至少有 1,055 萬美國成年人將患有心房顫動，是先前預測的三倍。

同時，3D電解剖標測與人工智慧融合的技術突破也正在推動市場發展。業界領導者正迅速部署高密度多電極導管和人工智慧驅動的軟體，這些軟體能夠自動檢測導致心律不整的基材，從而提高手術效率。這些創新直接滿足了複雜電生理病例中對精準度的臨床需求。這些新一代科技的商業性化應用顯然十分活躍。例如，雅培在2024年10月的財報中宣布，其電生理業務銷售額實現了14.3%的有機成長。這項業績主要得益於心臟定位產品兩位數的成長，這印證了業界正向先進、技術複雜的診斷解決方案轉型。

市場挑戰

心臟定位系統的購置和維護需要大量投資，這極大地阻礙了市場發展。高昂的初始投資往往是一個難題，尤其對於發展中地區的醫療機構。此外，專用導管和技術維護的持續成本也加劇了這一障礙，顯著增加了整體擁有成本。因此，資金有限的醫院常常推遲技術升級或繼續依賴過時的方法，這直接限制了可安裝的標測設備數量，並減少了這些地區製造商的潛在收入來源。

這些經濟限制因素導致臨床需求與實際技術應用之間存在顯著差距。雖然需要心律不整管理的患者人數不斷增加，但醫療預算的財政限制阻礙了這些設備的廣泛應用。世界心臟聯盟（WHF）預測，到2024年，心血管疾病將導致全球約2,050萬人死亡，凸顯了有效干預工具的緊迫性。然而，預算撥款往往難以承擔先進標測技術的高昂價格，使得製造商難以進入價格敏感型市場，減緩了整個產業的成長速度。

市場趨勢

心臟定位和脈衝電場消融(PFA) 技術的融合正在迅速改變競爭格局。隨著 PFA 系統因其能夠快速、非熱消融肺靜脈而日益受到臨床青睞，標測平台也在不斷發展，以實現與這些創新導管的無縫整合。這種技術協同作用能夠精確地可視化導管位置並評估病灶持久性，同時避免了傳統射頻消融方法所需的逐點精細標測。這種融合的影響是巨大的。根據 MedTech Dive 2024 年 10 月報道，波士頓科學公司第三季電生理相關銷售額年增 177%，這一成長主要歸功於市場對與該公司 PFA 系統兼容的標測工具的強勁需求。

同時，業界正朝著非接觸式、非侵入式標測解決方案發展。這些方案旨在透過在插入導管前利用表面電極和先進的計算模型重建心臟的3D電生理圖，從而簡化手術流程並提高安全性。這種方法顯著縮短了術中標測所需的時間，並最大限度地減少了患者接受電離輻射的風險。為了展示此調查方法的實際應用優勢，Vector Medical 於 2024 年 4 月發布了研究成果。根據這些研究結果，與標準治療相比，其基於人工智慧的非侵入式標測技術將心律不整消融手術中的透視時間縮短了 43.7%。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球心臟定位設備市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依類型（接觸式心臟定位系統、非接觸式心臟定位系統）
    • 適應症（心房顫動、心房撲動等）
    • 透過申請（醫院、診斷中心等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美心臟定位設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲心臟定位設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區心臟定位設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲心臟定位設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲心臟定位設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球心臟定位設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Abbott
  • Biosense Webster
  • Boston Scientific
  • Siemens Healthineers
  • Medtronic
  • Acutus Medical
  • Boston Scientific
  • GE Healthcare
  • Philips
  • MicroPort

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 26642

The Global Cardiac Mapping Devices Market is projected to expand from USD 2.99 Billion in 2025 to USD 5.69 Billion by 2031, registering a CAGR of 11.32%. These diagnostic instruments are essential in electrophysiology procedures, utilizing catheter-based sensors to capture and analyze the heart's electrical signals. By generating precise three-dimensional models of cardiac chambers, these systems allow physicians to accurately identify the anatomical sources of complex arrhythmias, such as atrial fibrillation. The real-time electrical data provided by these tools is critical for guiding ablation catheters to the specific tissues responsible for irregular heartbeats, thereby enhancing treatment efficacy and improving patient outcomes in cardiac care.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.99 Billion
Market Size 2031USD 5.69 Billion
CAGR 2026-203111.32%
Fastest Growing SegmentContact Cardiac Mapping Systems
Largest MarketNorth America

Market growth is largely fueled by the rising global burden of cardiovascular diseases and an aging population that is increasingly prone to rhythm disorders. This demand is further supported by a clinical shift toward minimally invasive ablation techniques, which rely on precise navigational capabilities. According to the European Society of Cardiology, projections for 2025 indicate that one in three individuals worldwide will face a potentially life-threatening heart rhythm disorder during their lifetime. However, despite this urgent clinical need, the market encounters significant obstacles due to the high costs associated with acquiring and maintaining these systems, which restricts their accessibility in developing healthcare infrastructures with limited financial resources.

Market Driver

The increasing prevalence of cardiovascular diseases and arrhythmias serves as a primary catalyst for market momentum. As the incidence of complex rhythm disorders like atrial fibrillation rises, there is a critical need for advanced mapping systems to facilitate curative ablation procedures. This epidemiological burden results in higher procedural volumes and a growing demand for accurate diagnostic tools. The American Heart Association's "2024 Heart Disease and Stroke Statistics" report indicates that cardiovascular disease continues to be the leading cause of global mortality, claiming approximately 19.91 million lives annually. Furthermore, the National Heart, Lung, and Blood Institute estimated in 2024 that at least 10.55 million American adults are expected to suffer from atrial fibrillation, a figure three times higher than previous predictions.

Concurrently, the market is propelled by technological breakthroughs in 3D electro-anatomical mapping and the integration of artificial intelligence. Industry leaders are rapidly deploying high-density multi-electrode catheters and AI-driven software that automate the detection of arrhythmogenic substrates, thereby improving procedural efficiency. These innovations directly address the clinical demand for precision in complex electrophysiology cases. The strong commercial adoption of these next-generation technologies is evident; for instance, Abbott reported in their October 2024 results that Electrophysiology sales grew by 14.3 percent on an organic basis, a performance driven specifically by double-digit growth in cardiac mapping products, confirming the industry's shift toward sophisticated, tech-enabled diagnostic solutions.

Market Challenge

The substantial financial investment required to purchase and sustain cardiac mapping systems constitutes a major restraint on market progression. Healthcare facilities, particularly those in developing regions, often find the initial capital expenditure prohibitive. This barrier is compounded by recurring expenses for specialized catheters and technical maintenance, which significantly increases the total cost of ownership. Consequently, hospitals with limited funding often postpone technology upgrades or rely on conventional methods, directly limiting the installed base of mapping units and reducing potential revenue streams for manufacturers in these territories.

This economic constraint creates a distinct gap between clinical necessity and actual technology adoption. While the patient population requiring arrhythmia management is expanding, the financial rigidity of healthcare budgets limits the penetration of these devices. According to the World Heart Federation, cardiovascular diseases caused approximately 20.5 million deaths globally in 2024, underscoring the urgent need for effective intervention tools. However, because budget allocations often cannot accommodate the premium pricing of advanced mapping technologies, manufacturers face difficulties expanding into price-sensitive markets, thereby slowing the overall growth trajectory of the industry.

Market Trends

The convergence of cardiac mapping with Pulsed Field Ablation (PFA) technologies is rapidly reshaping the competitive landscape. As PFA systems become clinically preferred for their ability to deliver rapid, non-thermal pulmonary vein isolation, mapping platforms are evolving to ensure seamless integration with these innovative catheters. This technological synergy allows for precise visualization of catheter placement and assessment of lesion durability without the extensive point-by-point mapping required by traditional radiofrequency methods. The impact of this integration is profound; MedTech Dive reported in October 2024 that Boston Scientific saw a 177% increase in third-quarter electrophysiology sales year-over-year, a surge attributed primarily to the high demand for its PFA system and compatible mapping tools.

Simultaneously, the industry is witnessing a shift toward non-contact and non-invasive mapping solutions designed to streamline procedural workflows and enhance safety. These advanced systems employ body-surface electrodes and sophisticated computational modeling to reconstruct 3D electrical maps of the heart before invasive catheters are introduced. This approach significantly reduces the time required for intra-procedural mapping and minimizes patient exposure to ionizing radiation. Validating the operational benefits of this methodology, Vektor Medical published study results in April 2024 showing that their AI-based non-invasive mapping technology led to a 43.7% reduction in fluoroscopy duration during arrhythmia ablation procedures compared to the standard of care.

Key Market Players

  • Abbott
  • Biosense Webster
  • Boston Scientific
  • Siemens Healthineers
  • Medtronic
  • Acutus Medical
  • Boston Scientific
  • GE Healthcare
  • Philips
  • MicroPort

Report Scope

In this report, the Global Cardiac Mapping Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cardiac Mapping Devices Market, By Type

  • Contact Cardiac Mapping Systems
  • Non-Contact Cardiac Mapping Systems

Cardiac Mapping Devices Market, By Indication

  • Atrial Fibrillation
  • Atrial Flutter
  • Others

Cardiac Mapping Devices Market, By End-use

  • Hospitals
  • Diagnostic Centers
  • Others

Cardiac Mapping Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cardiac Mapping Devices Market.

Available Customizations:

Global Cardiac Mapping Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cardiac Mapping Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Contact Cardiac Mapping Systems, Non-Contact Cardiac Mapping Systems)
    • 5.2.2. By Indication (Atrial Fibrillation, Atrial Flutter, Others)
    • 5.2.3. By End-use (Hospitals, Diagnostic Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Cardiac Mapping Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Indication
    • 6.2.3. By End-use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cardiac Mapping Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Indication
        • 6.3.1.2.3. By End-use
    • 6.3.2. Canada Cardiac Mapping Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Indication
        • 6.3.2.2.3. By End-use
    • 6.3.3. Mexico Cardiac Mapping Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Indication
        • 6.3.3.2.3. By End-use

7. Europe Cardiac Mapping Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Indication
    • 7.2.3. By End-use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cardiac Mapping Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Indication
        • 7.3.1.2.3. By End-use
    • 7.3.2. France Cardiac Mapping Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Indication
        • 7.3.2.2.3. By End-use
    • 7.3.3. United Kingdom Cardiac Mapping Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Indication
        • 7.3.3.2.3. By End-use
    • 7.3.4. Italy Cardiac Mapping Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Indication
        • 7.3.4.2.3. By End-use
    • 7.3.5. Spain Cardiac Mapping Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Indication
        • 7.3.5.2.3. By End-use

8. Asia Pacific Cardiac Mapping Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Indication
    • 8.2.3. By End-use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cardiac Mapping Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Indication
        • 8.3.1.2.3. By End-use
    • 8.3.2. India Cardiac Mapping Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Indication
        • 8.3.2.2.3. By End-use
    • 8.3.3. Japan Cardiac Mapping Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Indication
        • 8.3.3.2.3. By End-use
    • 8.3.4. South Korea Cardiac Mapping Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Indication
        • 8.3.4.2.3. By End-use
    • 8.3.5. Australia Cardiac Mapping Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Indication
        • 8.3.5.2.3. By End-use

9. Middle East & Africa Cardiac Mapping Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Indication
    • 9.2.3. By End-use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cardiac Mapping Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Indication
        • 9.3.1.2.3. By End-use
    • 9.3.2. UAE Cardiac Mapping Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Indication
        • 9.3.2.2.3. By End-use
    • 9.3.3. South Africa Cardiac Mapping Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Indication
        • 9.3.3.2.3. By End-use

10. South America Cardiac Mapping Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Indication
    • 10.2.3. By End-use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cardiac Mapping Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Indication
        • 10.3.1.2.3. By End-use
    • 10.3.2. Colombia Cardiac Mapping Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Indication
        • 10.3.2.2.3. By End-use
    • 10.3.3. Argentina Cardiac Mapping Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Indication
        • 10.3.3.2.3. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cardiac Mapping Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Biosense Webster
  • 15.3. Boston Scientific
  • 15.4. Siemens Healthineers
  • 15.5. Medtronic
  • 15.6. Acutus Medical
  • 15.7. Boston Scientific
  • 15.8. GE Healthcare
  • 15.9. Philips
  • 15.10. MicroPort

16. Strategic Recommendations

17. About Us & Disclaimer